Export & Import of Lethal Agents Mediated by TolC
出口
基本信息
- 批准号:7104845
- 负责人:
- 金额:$ 21.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-05 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Transport of molecules across biological membranes is a fundamental process shared by all living cells. In Gram-negative bacteria, such as Escherichia coil, transport occurs across two membranes, of which the outer membrane represents the first permeability barrier. Outer membrane protein-mediated transport is needed to bring nutrients inside and expel unwanted metabolites and inhibitors. Ironically, toxic biomolecules and infectious agents, present in the hostile environment in which bacteria live, frequently exploit these outer membrane proteins to gain entry into the cell. The focus of this research is a unique outer membrane protein, TolC, which mediates the diffusion of a diverse group of molecules including the export of alpha-hemolysin and the efflux of antibiotics. Despite the resolution of TolC's three-dimensional structure, the role of individual residues and the mechanism by which it accomplishes the transport of a diverse group of molecules remains poorly understood. Moreover, it is unknown how TolC interacts with other proteins of the inner membrane to form the complexes that facilitate the two-way transport activity. The present study is being undertaken to examine the role of TolC in export (antibiotic) and import (colicin E1 ), as well as to examine its interactions with other proteins of the transport complexes. Identification of functionally critical TolC residues and the various protein-protein interactions that must occur to accomplish the diverse transport activities will be achieved through employing a combination of genetic, structural, and biochemical approaches; available preliminary data concerning all aspects of the project strongly reflect their feasibility.The presence of TolC and its homologues in other Gram-negative bacteria demonstrates the broader relevance of this unique multifunctional protein. Besides the obvious role of TolC in antibiotic resistance, its ability to mediate the secretion of a variety of virulence factors in pathogenic bacteria makes it a medically important subject of investigation.
描述(由申请人提供):分子穿过生物膜的运输是所有活细胞共有的基本过程。在革兰氏阴性细菌中,如大肠杆菌,转运发生在两个膜上,其中外膜代表第一个渗透屏障。需要外膜蛋白介导的运输将营养物质带入内部并排出不需要的代谢物和抑制剂。具有讽刺意味的是,存在于细菌生存的恶劣环境中的有毒生物分子和感染因子经常利用这些外膜蛋白进入细胞。这项研究的重点是一种独特的外膜蛋白TolC,它介导多种分子的扩散,包括α-溶血素的输出和抗生素的外排。尽管TolC的三维结构的分辨率,单个残基的作用和它完成不同的分子组的运输的机制仍然知之甚少。此外,还不知道TolC如何与内膜的其他蛋白质相互作用以形成促进双向转运活性的复合物。目前的研究正在进行检查的作用TolC在出口(抗生素)和进口(大肠杆菌素E1),以及检查其与其他蛋白质的运输复合物的相互作用。鉴定功能关键的TolC残基和各种蛋白质-蛋白质相互作用,必须发生以完成不同的运输活动,将通过采用遗传,结构和生物化学方法的组合来实现;关于该项目所有方面的现有初步数据强烈反映了其可行性。TolC及其同系物在其他革兰氏阴性菌中的存在,阴性细菌证明了这种独特的多功能蛋白质的更广泛的相关性。除了TolC在抗生素耐药性中的明显作用外,其介导病原菌中多种毒力因子分泌的能力使其成为医学上重要的研究课题。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genetic assessment of the role of AcrB β-hairpins in the assembly of the TolC-AcrAB multidrug efflux pump of Escherichia coli.
- DOI:10.1111/mmi.12508
- 发表时间:2014-03
- 期刊:
- 影响因子:3.6
- 作者:Weeks JW;Bavro VN;Misra R
- 通讯作者:Misra R
Assembly and channel opening in a bacterial drug efflux machine.
- DOI:10.1016/j.molcel.2008.02.015
- 发表时间:2008-04-11
- 期刊:
- 影响因子:16
- 作者:Bavro, Vassiliy N.;Pietras, Zbigniew;Furnham, Nicholas;Perez-Cano, Laura;Fernandez-Recio, Juan;Pei, Xue Yuan;Misra, Rajeev;Luisi, Ben
- 通讯作者:Luisi, Ben
AcrA suppressor alterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening.
- DOI:10.1111/j.1365-2958.2010.07068.x
- 发表时间:2010-03
- 期刊:
- 影响因子:3.6
- 作者:Weeks JW;Celaya-Kolb T;Pecora S;Misra R
- 通讯作者:Misra R
Assembly and transport mechanism of tripartite drug efflux systems.
- DOI:10.1016/j.bbapap.2009.02.017
- 发表时间:2009-05
- 期刊:
- 影响因子:0
- 作者:Misra R;Bavro VN
- 通讯作者:Bavro VN
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAJEEV MISRA其他文献
RAJEEV MISRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAJEEV MISRA', 18)}}的其他基金
Detailed mapping of drug binding and translocation sites in the AcrB pump protein
AcrB 泵蛋白中药物结合和易位位点的详细图谱
- 批准号:
9210599 - 财政年份:2016
- 资助金额:
$ 21.04万 - 项目类别:
Detailed mapping of drug binding and translocation sites in the AcrB pump protein
AcrB 泵蛋白中药物结合和易位位点的详细图谱
- 批准号:
9112330 - 财政年份:2016
- 资助金额:
$ 21.04万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI OUTER MEMBRANE PROTEINS
大肠杆菌外膜蛋白的靶向和组装
- 批准号:
6018920 - 财政年份:1992
- 资助金额:
$ 21.04万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI OUTER MEMBRANE PROTEINS
大肠杆菌外膜蛋白的靶向和组装
- 批准号:
2185646 - 财政年份:1992
- 资助金额:
$ 21.04万 - 项目类别:
TARGETING AND ASSEMBLY OF E COLI OUTER MEMBRANE PROTEINS
大肠杆菌外膜蛋白的靶向和组装
- 批准号:
6179580 - 财政年份:1992
- 资助金额:
$ 21.04万 - 项目类别:
相似海外基金
Development of rapid detection method for drug-resistant bacteria in pulmonary MAC disease and search for new antibacterial agents
肺部MAC疾病耐药菌快速检测方法的建立及新型抗菌药物的寻找
- 批准号:
23K07930 - 财政年份:2023
- 资助金额:
$ 21.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
- 批准号:
23K07918 - 财政年份:2023
- 资助金额:
$ 21.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ATP Synthase as an emerging target for the pre-clinical development of broad-spectrum antibacterial agents against drug-resistant bacterial infections
ATP 合酶作为针对耐药细菌感染的广谱抗菌药物临床前开发的新兴靶标
- 批准号:
472342 - 财政年份:2022
- 资助金额:
$ 21.04万 - 项目类别:
Operating Grants
Clinical application of a rapid assay for antibacterial susceptibility test of beta-lactams and carbapenems antibacterial agents using MALDI-TOF MS
MALDI-TOF MS快速测定β-内酰胺类和碳青霉烯类抗菌药物药敏试验的临床应用
- 批准号:
22K07406 - 财政年份:2022
- 资助金额:
$ 21.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tailored and uniform fibre-like micelles as antibacterial agents.
定制且均匀的纤维状胶束作为抗菌剂。
- 批准号:
569719-2022 - 财政年份:2022
- 资助金额:
$ 21.04万 - 项目类别:
Postgraduate Scholarships - Doctoral
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2022
- 资助金额:
$ 21.04万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2021
- 资助金额:
$ 21.04万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2021
- 资助金额:
$ 21.04万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2020
- 资助金额:
$ 21.04万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents.
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体。
- 批准号:
531450-2018 - 财政年份:2020
- 资助金额:
$ 21.04万 - 项目类别:
Collaborative Research and Development Grants